ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.060,68
-0,39%
S&P 500
5.116,17
0,32%
Dow Jones
38.386,09
0,38%
Euro vs US Dollar
1,07355
0,19%
Bitcoin
61.695,37
-3,36%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DatumZeitQuelleÜberschriftSymbolFirma
24/04/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at Planet MicroCap ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/04/202422h15GlobeNewswire Inc.Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/03/202414h32GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at BIO-Europe SpringNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/03/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/03/202413h00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/03/202415h37GlobeNewswire Inc.New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/03/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/03/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of TherapyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/202423h01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/03/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/03/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in HumansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/02/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/02/202423h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/02/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/02/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/02/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/02/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/02/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy VolunteersNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
27/02/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
27/02/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and ChinaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
23/02/202415h30GlobeNewswire Inc.New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised SeriesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/02/202414h00GlobeNewswire Inc.Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/02/202415h30GlobeNewswire Inc.New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
CCOM
US100
US Tech 100
TG
CBK
Commerzbank
USOTC
BASFY
BASF (QX)
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
TG
LHA
Deutsche Lufthansa
AMEX
SPY
SPDR S&P 500
FX
EURGBP
Euro vs Sterling
CCOM
US500
US 500
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
DBI
DAX
DAX
TG
DBK
Deutsche Bank
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten